Courtney Stanton Headshot

Courtney E. Stanton


Courtney E. Stanton serves as President of Smithfield BioScience and the Vice President Bioproducts for Smithfield Foods, Inc., a $15 billion global food company founded and headquartered in Smithfield, Virginia. In this role, Stanton leads the Smithfield BioScience strategic platform, leveraging byproducts from the meat production process for the development of pharmaceuticals, regenerative medicine, nutraceuticals, and medical device solutions.

Stanton joined Smithfield in 2015 and brings extensive experience in commercializing new ventures, business development, new product development, portfolio management, and acquisitions. She has played a pivotal role in establishing Smithfield as a leader in providing a range of biotechnology solutions in the areas of human therapeutics and tissue fabrication, and for growing Smithfield’s overall byproducts business year-over-year.

Prior to joining Smithfield, Stanton held leadership positions at several large companies in the food industry, including Tate & Lyle, Fonterra U.S.A., and Tyson Foods. Throughout her career, Stanton has served in a variety of business development roles and was responsible for numerous successful ventures into new international markets.

Stanton is a member of the Society for Biological Engineering and the Harvard Business School Angel Investors. She earned her B.A. in International Relations and Economics from Wellesley College and her MBA from Harvard Business School.

Scott Webster

Scott Webster

General Manager

Scott Webster is currently the General Manager for Smithfield BioScience. In this role he leads the team at the facility in Cincinnati commercializing and manufacturing bioproducts derived from pigs.

Webster is an animal agriculture authority on a broad basis of areas of expertise including animal nutrition, pharmaceuticals, live production operations management, supply chain sales and management, and financial decisions throughout the entire animal protein value chain. He has 17 years previous experience within Smithfield Foods live production companies/acquisitions where he progressed through technical and management roles culminating in the final 7 years where he served in a senior leadership role as a Vice President/General Manager of Production Operations in North Carolina.

Prior to rejoining Smithfield in 2017, Webster held multiple roles in the animal feed industry in sales, technical and management roles. He has previous pharmaceutical company experience with Pfizer Animal Health (now Zoetis) where he provided leadership and implementation experience for the introduction of new technology throughout the US swine industry.

Mr. Webster grew up on the family farm in Minnesota, was technically trained as a swine nutritionist and maintains certification credentials as a Professional Animal Scientist (PAS) through the American Registry of Professional Animal Scientists. He holds a B.S. in Animal Science with a minor in Agricultural Economics from the University of Minnesota, and an M.S. in Animal Science from the University of Missouri.

David Hufnagle

David Hufnagle

Director of Quality Control, Quality Assurance,
and Regulatory Affairs

Dr. Hufnagle joined Smithfield BioScience in his current position in June 2017.  Hufnagle leads the quality control, quality assurance, and regulatory affairs functions.  He has extensive experience in GMP quality systems and facilitating product approvals with global regulatory bodies. Dr. Hufnagle spent the 5 previous years at former independent operating company Celsus Laboratories, where he led the quality assurance and regulatory affairs groups. Hufnagle holds a B.S. in Chemistry from the University of Dayton and a Ph.D. in Analytical Chemistry from Miami University.

Warren Van Gorp

Warren Van Gorp

Plant Manager

Mr. Van Gorp has provided management leadership of the manufacturing operations of Smithfield BioScience’s Heparin Operation since 1996. He has extensive experience in API production and new product development. Van Gorp became plant manager at Smithfield BioScience in 2019.  Prior to the acquisition, he spent 21 years at former independent operating company Celsus Laboratories, where he managed the production operations for heparin and heparin derivatives, including low molecular weight heparins, ardeparin and enoxaparin.  Van Gorp is a foreign war combat veteran of the United States Marine Corps.

Melissa Jones

Melissa I. Jones


As the controller and business administrator for Smithfield BioScience, Melissa’s primary areas of responsibility include financial reporting and analysis, budgeting, compliance with SOX and annual internal auditing, general ledger accounting, operational/cost accounting, inventory management, and personnel management.  In this role, Melissa is also responsible for directing day to day office functions, including the overall business administration of the facility. Melissa actively serves the Cincinnati community through not-for-profit board service and individual service hours as a member of The Junior League, Jack & Jill of America, Incorporated; Top Ladies of Distinction, Incorporated; and Zeta Phi Beta Sorority, Incorporated where she is treasurer of the International Executive Board. A 21-year finance professional and Six Sigma Green Belt, she obtained an MBA from the University of Missouri and is a Certified Internal Audit Practitioner.